Literature DB >> 19850225

Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis.

Helen A Weiss1, Catherine A Hankins, Kim Dickson.   

Abstract

Male circumcision provides long-term indirect protection to women by reducing the risk of heterosexual men becoming infected with HIV. In this Review, we summarise the evidence for a direct effect of male circumcision on the risk of women becoming infected with HIV. We identified 19 epidemiological analyses, from 11 study populations, of the association of male circumcision and HIV risk in women. A random-effects meta-analysis of data from the one randomised controlled trial and six longitudinal analyses showed little evidence that male circumcision directly reduces risk of HIV in women (summary relative risk 0.80, 95% CI 0.53-1.36). Definitive data would come from a further randomised controlled trial of circumcision among men infected with HIV in serodiscordant heterosexual relationships, but this would involve enrolling about 10 000 couples and is likely to be logistically unfeasible. As circumcision services for HIV prevention are scaled-up in high HIV prevalence settings, rapid integration with existing prevention strategies would maximise benefits for both men and women. Rigorous monitoring is essential to ensure that any adverse effects on women are detected and minimised.

Entities:  

Mesh:

Year:  2009        PMID: 19850225     DOI: 10.1016/S1473-3099(09)70235-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  54 in total

1.  Does sexual function survey in Denmark offer any support for male circumcision having an adverse effect?

Authors:  Brian J Morris; Jake H Waskett; Ronald H Gray
Journal:  Int J Epidemiol       Date:  2011-11-28       Impact factor: 7.196

2.  Newborn male circumcision.

Authors:  S Todd Sorokan; Jane C Finlay; Ann L Jefferies
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

3.  Towards a gender perspective in qualitative research on voluntary medical male circumcision in east and southern Africa.

Authors:  Guillermo Martínez Pérez; Laura Triviño Durán; Angel Gasch; Nicole Desmond
Journal:  Glob Public Health       Date:  2015-03-02

4.  Female Partner Acceptance as a Predictor of Men's Readiness to Undergo Voluntary Medical Male Circumcision in Zambia: The Spear and Shield Project.

Authors:  Ryan Cook; Deborah Jones; Colleen A Redding; Robert Zulu; Ndashi Chitalu; Stephen M Weiss
Journal:  AIDS Behav       Date:  2016-11

5.  Factors associated with the early resumption of sexual activity following medical male circumcision in Nyanza province, Kenya.

Authors:  Amy Herman-Roloff; Robert C Bailey; Kawango Agot
Journal:  AIDS Behav       Date:  2012-07

6.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (abridged version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

Review 7.  Abstinence promotion under PEPFAR: the shifting focus of HIV prevention for youth.

Authors:  John S Santelli; Ilene S Speizer; Zoe R Edelstein
Journal:  Glob Public Health       Date:  2013-01-18

Review 8.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

9.  Medical male circumcision and HIV risk: perceptions of women in a higher learning institution in KwaZulu-Natal, South Africa.

Authors:  Joanne E Mantell; Jennifer A Smit; Jane L Saffitz; Cecilia Milford; Nzwakie Mosery; Zonke Mabude; Nonkululeko Tesfay; Sibusiso Sibiya; Letitia Rambally; Tsitsi B Masvawure; Elizabeth A Kelvin; Zena A Stein
Journal:  Sex Health       Date:  2013-05       Impact factor: 2.706

10.  Male circumcision: integrating tradition and medical evidence.

Authors:  Seema Kacker; Aaron A R Tobian
Journal:  Isr Med Assoc J       Date:  2013-01       Impact factor: 0.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.